{"id":"W4390767843","doi":"10.1016/j.eclinm.2023.102405","title":"Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial","year":2024,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Aeglea BioTherapeutics","keywords":"Medicine; Placebo; Double blind; Arginase; Randomized controlled trial; Placebo-controlled study; Physical therapy; Internal medicine; Alternative medicine; Pathology; Arginine; Biochemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002423527,0.001902297,0.002692007,0.0004247617,0.0004501323,0.001287784,0.0008806546,0.00208885,0.005846902],"category_scores_gemma":[0.001770694,0.0006134751,0.002125061,0.0004220673,0.001037969,0.001250705,0.0003846729,0.002938169,0.00105327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006970788,"about_ca_system_score_gemma":0.001319288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004592369,"about_ca_topic_score_gemma":0.0008610606,"domain_scores_codex":[0.9993269,0.000331554,0.00004071991,0.0001351519,0.00005500846,0.0001106084],"domain_scores_gemma":[0.999109,0.0002031024,0.0002537001,0.00008499437,0.00007113814,0.0002780808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9826399,0.004346213,0.0003883366,0.0004665758,0.0006213374,0.0000327582,0.0000415703,0.0002229071,0.002938682,0.00007185445,0.0005731233,0.00765672],"study_design_scores_gemma":[0.9582045,0.03955195,0.0008536213,0.00002214571,0.0003116061,0.00003551058,0.00001236029,0.0002020822,0.0003550882,0.0000812853,0.0003609415,0.000008894305],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821391,0.005793409,0.001071052,0.0009255242,0.0005395513,0.005857496,0.001676682,0.0002486303,0.001748536],"genre_scores_gemma":[0.9799262,0.003660875,0.00210287,0.001372639,0.0004967238,0.008051443,0.001727232,0.00004575919,0.00261639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005846902,"threshold_uncertainty_score":0.0195598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02784344415186302,"score_gpt":0.355487212634591,"score_spread":0.327643768482728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}